HZNP - Horizon Therapeutics ticks higher amid Nasdaq delisting notice for sale to Amgen
2023-10-02 16:39:05 ET
More on Horizon Therapeutics
- Horizon Therapeutics: Can Investors Profit From Amgen Deal Confusion?
- Improved Outlook For Horizon Therapeutics And Amgen
- Horizon Therapeutics ticks higher as Amgen end date extended until December (update)
- Irish High Court hearing for Horizon's $28B sale to Amgen set for Oct. 5
- Seeking Alpha’s Quant Rating on Horizon Therapeutics
For further details see:
Horizon Therapeutics ticks higher amid Nasdaq delisting notice for sale to Amgen